An experimental vaccine kept melanoma from returning or spreading in people at high risk of the skin cancer recurring, drugmakers Moderna and Merck announced Wednesday.
source https://medicalxpress.com/news/2026-08-personalized-vaccine-melanoma-patients-stay.html
source https://medicalxpress.com/news/2026-08-personalized-vaccine-melanoma-patients-stay.html
Comments
Post a Comment